depigmentation

Disorders of Depigmentation: Focus on Vitiligo
vitiligo
by Emily Murphy, MD on
At the 2023 ODAC Dermatology, Aesthetic & Surgical Conference, we were lucky to learn about the management of vitiligo from the renowned researcher and clinician, Dr.  John Harris, Professor and Chair of Dermatology at the University of Massachusetts. When a new patient with vitiligo presents to my clinic, I always pull out my phone to consult Dr. Harris’ treatment protocol – I am sure I …
Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy
Tofacitinib
by NEXT STEPS IN DERM TEAM on
INTRODUCTION Tofacitinib is a Janus kinase (JAK) 1-3 inhibitor first U.S. Food and Drug Administration (FDA) approved in 2012 for rheumatoid arthritis, with subsequent approval for psoriatic arthritis, ulcerative colitis, polyarticular course juvenile idiopathic arthritis, and ankylosing spondylitis in 2017, 2018, 2020, and 2021, respectively.1,2 In the last several years, oral tofacitinib …
Hydroquinone Therapeutic Cheat Sheet
hydroquinone
by Kamaria Nelson, MD on
Hydroquinone is the most commonly used depigmentation agent and is a first-line treatment for melasma.1Hydroquinone was available previously in over-the-counter products and is currently available in prescription formulations with common concentration ranges of 0.4 to 5%. Prescription strengths available in the United States include hydroquinone 2% and 4% cream and hydroquinone 2% gel.2,3 In Septe …
Current and Emerging Management Strategies for Vitiligo
vitiligo
by Saleh Rachidi, MD, PhD on
Vitiligo is an autoimmune skin disease that affects >3 million individuals in the US and around 74 million worldwide. In addition to physical symptoms such as itch, it can be particularly cosmetically concerning and psychologically distressing. It mainly affects young individuals, where it is estimated that 50% of cases have onset before the age of 20. Importantly, it is associated with other a …
What’s New on the Vitiligo Treatment Horizon
New Vitiligo Treatments
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. John Harris, Vice-Chair of Dermatology and Director of the Vitiligo Clinic and Research Center at UMass Medical School in Worcester, Massachusetts, on new vitiligo treatments in the horizon. Watch as he shares recent discoveries that have influenced the way that we diagnose and manage pat …